PetVivo Holdings, Inc. PETV

PetVivo Holdings, Inc. appointed Michael K. Handley to its Board of Directors, effective Sept. 22, 2026, filling the vacancy left by Joseph Jasper and bringing the board to six members. Handley, a life sciences executive with 25+ years in biotech, pharma and medical devices, has raised over $700 million in public and private capital, supported more than 80 product launches, and contributed to transactions exceeding $4 billion. He has led or advised roles at Valion Bio, Statera Biopharma, Immune Therapeutics, Armis Biopharma, and helped found Vessix Vascular, acquired by Boston Scientific in 2012. Handley holds a B.S. in Molecular Biology and Physiology from Colorado State and has completed executive programs at Pepperdine and Wharton. PetVivo's lead product SPRYNG with OsteoCushion is sold for joint ailments in animals; company aims to expand adoption and pursue human health applications while pursuing shareholder value. Forward-looking statements disclaimer. A seasoned life sciences executive joining the board is likely to enhance capital-raising, strategic partnerships and commercialization efforts, influencing growth.

PetVivo Holdings, Inc. announced the appointment of Jaime K. Pickett, DVM, MBA, to its Board of Directors, effective September 22, 2026. Pickett brings more than 20 years of veterinary-health leadership, including roles as Chief Medical Officer of EQUUSIR USA; Advising CMO and board member for Alexander International Innovations; and governance work with Chief Veterinary Medical Officers and Scenthound. She previously led Hannah Pet Hospitals (CEO, President, CSO and board member, 2023–2026) and served as Chief Veterinary Officer and SVP at Pet Paradise, plus COO of NewDay Veterinary Care (2017–2022). Her background spans clinical practice, hospital operations, expansion and telehealth. She holds a DVM from the University of Florida, an MBA from St. George's University, a Johns Hopkins BA, and completed Wharton’s Global C-Suite program. She fills the vacancy created by Diane Levitan’s resignation; the Board remains six directors. PetVivo’s lead product SPRYNG with OsteoCushion technology is commercially available. Brings a highly experienced veterinary-health executive to the board, which could improve strategy and veterinary relationships, potentially influencing mid-term growth.

PetVivo Holdings, Inc. renamed its human subsidiary to Somatrix Technologies, Inc. and expanded its focus on human health innovation. Subsidiary rebrand plus human health expansion signals moderate strategic shift affecting positioning without immediate transformative results.

PetVivo Holdings Inc (PETV) reported revenue growth and outlined strategic initiatives during its Q1 2027 earnings call. Revenue growth and strategic updates from the earnings call point to moderate effects on financial performance and positioning.

PetVivo Holdings reports financial results for fiscal Q1 2027. Q1 2027 results offer data on operations that can shift near-term market views.

PetVivo Holdings announced publication of a peer-reviewed clinical study evaluating Spryng in Veterinary Record. Peer-reviewed study publication on Spryng may boost product acceptance among veterinarians.

PetVivo Holdings Inc reported Q4 2026 earnings call highlights focused on pursuing growth while managing operational and market challenges. Quarterly earnings updates with mixed growth and challenge commentary typically produce moderate short-term effects on company valuation and sentiment.

PetVivo Holdings, Inc. released financial and operational results for fiscal 2026. Quarterly financial results provide updated performance data that can moderately shift investor views on operations and valuation.

PetVivo Holdings acquires PiezoBioMembrane to build a leading functional biomaterials platform. Transformative acquisition represents major strategic move that significantly alters PetVivo's competitive trajectory and product capabilities.

PetVivo Holdings Inc (PETV) Q3 2026 earnings call highlights strategic partnerships and AI advancements driving future growth. Strategic partnerships and AI features in earnings call indicate major boosts to competitive positioning and market trajectory.

PetVivo Holdings, Inc. (PETV) reported financial results for the third quarter and first nine months of fiscal 2026. Quarterly earnings reports typically drive significant shifts in stock price and investor perceptions of future performance.

PetVivo Holdings, Inc. (PETV) is featured on New to The Street, airing on Bloomberg Television across the U.S., MENA, and Latin America. The segment highlights the company's innovative products and advancements in the veterinary market, aiming to increase visibility and investor interest. Increased visibility through media exposure may moderately influence market sentiment and investor interest in PetVivo's products.

PetVivo Holdings, Inc. (PETV) was featured in a broadcast by New to The Street on Bloomberg, reaching audiences across the U.S., MENA, and Latin America. The segment highlighted the company's innovative products and advancements in the veterinary market, aiming to increase visibility and investor interest. Increased visibility through media exposure may enhance market sentiment and interest in PetVivo's products.

PetVivo Holdings, Inc. has received acknowledgment from Health Canada for its product, Spryng®, which is classified as a veterinary medical device. This recognition is expected to facilitate the product's availability in the Canadian market, enhancing the company's growth potential in veterinary medicine. Health Canada's acknowledgment of Spryng® as a veterinary medical device is a significant regulatory milestone that could enhance market access and investor confidence.

Digital Landia's AgenticPet has successfully attracted 1,000 beta users within just three days of its public launch, indicating strong initial interest and engagement with the platform. This rapid uptake suggests a promising start for the product in the pet technology market. The rapid user acquisition may positively influence PetVivo's market positioning and product innovation in the pet technology sector.

PetVivo Holdings, Inc. (PETV) is featured in New to The Street Show #710, airing tonight at 6:30 PM EST on Bloomberg Television. The segment will highlight the company's innovative products and advancements in the veterinary market, aiming to enhance visibility and investor interest. Increased visibility through media exposure may moderately influence market sentiment and investor interest.

PetVivo Holdings, Inc. will present at the 3rd Annual DealFlow Discovery Conference, showcasing its innovative veterinary products and technologies. The conference aims to connect investors with emerging companies in the pet industry, highlighting PetVivo's commitment to advancing animal health solutions. This presentation is expected to enhance visibility and attract potential investment opportunities for the company. Participation in a prominent conference may enhance visibility and attract investment, but the overall impact on the company's trajectory is expected to be limited.

Digital Landia and Influencer Hero are launching a 20% lifetime commission program aimed at creating a self-growing system for app users. The initiative is designed to increase local app users, which in turn enhances value for local veterinarians, encouraging them to become brand ambassadors and attract even more users. The commission program could moderately influence user growth and brand engagement, impacting PetVivo's market positioning.

PetVivo AI, Inc. has launched an AI platform designed to significantly reduce veterinary client acquisition costs by 50-90%. This innovative technology aims to enhance operational efficiency for veterinary practices, potentially transforming how they attract and retain clients. The platform leverages advanced algorithms to optimize marketing strategies and streamline client engagement, positioning PetVivo as a leader in veterinary technology solutions. The launch of the AI platform is expected to significantly impact PetVivo's market positioning and operational efficiency in the veterinary sector.

PetVivo Holdings, Inc. has launched an AI platform designed to significantly reduce veterinary client acquisition costs by 50-89%. This innovative technology aims to streamline the process for veterinary practices, potentially enhancing their operational efficiency and profitability. The introduction of this platform positions PetVivo to improve its market presence and attract more veterinary clients, thereby driving growth in the company's business model. The launch of the AI platform is expected to significantly enhance PetVivo's competitive positioning and operational efficiency in the veterinary market.

PetVivo Holdings, Inc. (PETV) reported record revenue in Q2 2026, highlighting significant growth and strategic initiatives aimed at expanding its market presence. The company emphasized its commitment to innovation and product development, which are expected to drive future performance. Management provided insights into operational efficiencies and upcoming product launches that could enhance competitive positioning. Record revenue and strategic initiatives indicate a significant impact on future performance and market positioning.

PetVivo Holdings, Inc. announced that Digital Landia has published a technical whitepaper validating the AgenticPet AI framework. This publication is part of an exclusive 10-year licensing agreement, which is expected to enhance the company's technological capabilities and market position in the pet healthcare sector. The exclusive licensing agreement and validation of the AI framework are likely to significantly impact PetVivo's strategic direction and competitive positioning.

PetVivo Holdings, Inc. (PETV) reported a 50% increase in revenues for fiscal Q2 2026, highlighting strong financial performance and growth in its product offerings. The company continues to expand its market presence and enhance its operational capabilities, positioning itself favorably in the industry. The significant revenue growth indicates a strong market position and potential for future expansion.

PetVivo Holdings, Inc. (PETV) is positioned to benefit from the rising pet healthcare spending, as the market for pet products and services continues to grow significantly. The company focuses on innovative solutions for pet health, which aligns with the increasing consumer demand for quality pet care. As pet owners prioritize their pets' health, companies like PetVivo are expected to see enhanced market opportunities and potential revenue growth. Rising pet healthcare spending is likely to significantly enhance PetVivo's market opportunities and revenue potential.

Digital Landia has published a technical whitepaper detailing the AgenticPet AI Framework after a year of development and stress testing. This framework aims to enhance the capabilities of pet-related technologies, potentially benefiting companies in the pet industry, including PetVivo Holdings, Inc. The introduction of the AgenticPet AI Framework may influence product innovation and competitive positioning in the pet technology market.

Josh Ruben has been appointed to the Board of Directors of PetVivo Holdings, Inc. His extensive experience in the medical device industry is expected to enhance the company's strategic direction and governance. Ruben's background includes leadership roles at various healthcare companies, which may contribute to PetVivo's growth and innovation in the veterinary market. Ruben's appointment could moderately influence PetVivo's strategic direction and governance, impacting its competitive positioning.

PetVivo Holdings, Inc. will present at Spartan Capital Securities' Second Annual Investor Conference, showcasing its innovative products and strategies to potential investors. This event aims to enhance visibility and attract investment interest in the company's offerings. Participation in investor conferences can moderately influence market sentiment and investor interest in the company's future prospects.

PetVivo Holdings, Inc. has entered a groundbreaking AI license agreement aimed at addressing the veterinary industry's challenges with Generation Z pet owners. This initiative focuses on enhancing engagement and improving veterinary practices to cater to the preferences of younger pet owners, leveraging advanced technology to better serve the market. The agreement is expected to position PetVivo favorably within the evolving landscape of veterinary care. The AI license agreement represents a significant strategic move that could enhance PetVivo's competitive positioning and market appeal.

PetVivo Holdings, Inc. has entered into a vendor partner agreement with Veterinary Growth Partners to enhance the distribution of its innovative veterinary therapeutics. This collaboration aims to expand access to PetVivo's products, which are designed to improve the quality of life for animals. The partnership is expected to leverage Veterinary Growth Partners' extensive network within the veterinary community, facilitating greater outreach and adoption of PetVivo's offerings. The partnership with Veterinary Growth Partners is a significant strategic move that could enhance market access and influence PetVivo's growth trajectory.

PetVivo Holdings, Inc. (PETV) is participating in the Accredited Investor Event hosted by New to The Street on October 21-22 at Hudson Yards, NYC. This event aims to connect investors with emerging companies, providing a platform for PetVivo to showcase its innovative products and business model to potential investors. Participation in investor events can moderately influence market sentiment and visibility for PetVivo's offerings.